Eight strains of a previously undescribed coryneform bacterium had been isolated from human clinical material over a 5-year period. Colonies of the unknown coryneform bacterium had an unusual appearance as they were slightly yellowish and very mucoid. Biochemical and chemotaxonomic characterization revealed that the unknown coryneform bacterium belonged to the genus Corynebacterium. It could be readily differentiated from all previously described Corynebacterium species. Electron microscopy demonstrated the production of an extracellular substance causing connecting filaments between cells as a morphological correlate to the mucoid colonies. Comparative 16s rRNA gene sequence analysis revealed that the unknown coryneform bacterium represented a new subline within the genus Corynebacterium, for which the name Corynebacteriurn mucifaciens sp. nov. is proposed. The type strain is CCUG 36878 (= DSM 44265 = CIP 105129).The genus Corynebacterium is the largest genus in the coryneform group of bacteria (i.e., aerobically growing, asporogenous, non-partially acid-fast, irregular gram-positive rods) and currently comprises more than 25 species (1 1). During the past decade, 12 new Corynebacterium species have been established (9,ll). Interestingly, all of these were derived from human clinical specimens, whereas only 7 of the 17 Corynebacterium species listed in Bergey's Manual of Systematic Bacteriology are considered medically relevant (4, 11). The present report deals with yet another novel Corynebacterium species isolated from human clinical specimens. Over a 5-year period, eight strains of a coryneform bacterium whose colonies were slightly yellowish and markedly mucoid were isolated from human clinical material. In a polyphasic approach including both phenotypic and molecular genetic methods, it was demonstrated that this coryneform bacterium represents a new Corynebacterium species, for which the name Corynebacterium rnucifaciens sp. nov. is proposed.
MATERIALS AND METHODSBacterial strains. The origins of the strains studied and their clinical sources are given in Table 1. Four strains were isolated by workers at the Department of Medical Microbiology, University of Zurich, Zurich, Switzerland, and four other isolates were received by the reference laboratory for coryneform bacteria of the same institution.Phenotypic characteristics. Strains were grown aerobically at 37°C in a 5% C0,-enriched atmosphere on Columbia agar (Difco, Detroit, Mich.) supplemented with 5% sheep blood. The methods used for biochemical profiling of the bacteria have been outlined in detail previously (8). By using the API Coryne system (bioMCrieux, Marcy l'Etoile, France), enzymatic reactions were determined after 24 h at 3TC, and acid production from carbohydrates was observed after 48 h of incubation. The API S0CH system (acid production from additional carbohydrates) was used in conjunction with 50CHE medium (both from bioMerieux), and reactions were read after 96 h of incubation at 37°C.Electron microscopy. Cells were grown in brain hea...